S100B Measured in Blood Samples as a Prognostic Biomarker of Functional Capacity and Vital Status in Moderate and Severe Traumatic Brain Injury Patients: Systematic Review and Meta-Analysis

S100B Measured in Blood Samples as a Prognostic Biomarker of Functional Capacity and Vital Status in Moderate and Severe Traumatic Brain Injury Patients: Systematic Review and Meta-Analysis

Moderate and severe traumatic brain injury (TBI) can lead to harmful consequences for trauma victims. S100B is a widely studied biomarker to predict the outcomes of this injury, but gaps in knowledge about this protein make its clinical application still uncertain. We investigated the potential prog...

Full description

Saved in:
Bibliographic Details
Main Authors: Lillian Caroline Fernandes, Dyenily Alessi Sloboda, Thamires de Oliveira Rocha, Lilia de Souza Nogueira, Ramon Antonio Oliveira, Augusto Magno Tranquezi Cordeiro, Wellingson Silva Paiva, Rita de Cassia Almeida Vieira, Leda Leme Talib, Regina Marcia Cardoso de Sousa
Format: Article
Language:English
Published: Mary Ann Liebert 2024-11-01
Series:Neurotrauma Reports
Subjects:
biomarkers
prognosis
S100B protein
systematic review
traumatic brain injury
Online Access:https://www.liebertpub.com/doi/10.1089/neur.2024.0101
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.liebertpub.com/doi/10.1089/neur.2024.0101

Similar Items